Filing Details
- Accession Number:
- 0000950170-24-021563
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-27 19:57:35
- Reporting Period:
- 2024-02-26
- Accepted Time:
- 2024-02-27 19:57:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1216955 | S Joel Marcus | C/O Alexandria Real Estate Equities,Inc. 26 North Euclid Avenue Pasadena CA 91101 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-26 | 20,000 | $43.45 | 49,233 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-02-26 | 16,757 | $55.48 | 65,990 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-26 | 8,371 | $67.83 | 57,619 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 17,658 | $69.07 | 39,961 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-02-26 | 299 | $69.60 | 39,662 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-02-26 | 20,000 | $0.00 | 20,000 | $43.45 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-02-26 | 16,757 | $0.00 | 16,757 | $55.48 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2031-06-20 | No | 4 | M | Direct | |
| 0 | 2032-06-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,000 | Indirect | See Footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.53 to $68.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.53 to $69.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $69.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
- Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
- All shares underlying this option have vested.
Billionaire Hedge Funds
